Notes - Segment Information

Astellas Pharma Inc. - Filing #7586679

Concept 2022-07-01 to
2022-09-30
As at
2022-09-30
2022-04-01 to
2022-09-30
As at
2022-03-31
2021-07-01 to
2021-09-30
2021-04-01 to
2021-09-30
Notes - Segment information
Segment information
Revenue
Revenue
380,394,000,000 JPY
762,185,000,000 JPY
325,523,000,000 JPY
651,666,000,000 JPY
Share of profit (loss) of investments accounted for using equity method
1,429,000,000 JPY
1,779,000,000 JPY
16,000,000 JPY
308,000,000 JPY
Profit (loss) before tax
88,801,000,000 JPY
120,480,000,000 JPY
53,255,000,000 JPY
89,085,000,000 JPY
Assets
2,583,661,000,000 JPY
2,332,395,000,000 JPY
Investments accounted for using equity method
14,316,000,000 JPY
10,035,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.